Investigating the Effects of Lipocalin Prostaglandin D2 Synthase, AT-56 on Non-Alcoholic Fatty Liver Disease Using HepG2 Cells

被引:0
|
作者
Agarwal, Nishant [1 ]
Khairnar, Rhema
Singh, Kuljeet [1 ]
Kumar, Sunil
机构
[1] St Johns Univ, Queens, NY USA
关键词
D O I
10.1016/j.jpet.2025.103443
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
191932
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Investigating the Intertwine Effect of Insulin Resistance and Lipocalin Prostaglandin D2 Synthase in Non-alcoholic Fatty Liver Disease using HepG2 Cells
    Khairnar, Rhema
    Islam, Md Asrarul
    Kumar, Sunil
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [2] Lipocalin-type prostaglandin D2 synthase deletion induces dyslipidemia and non-alcoholic fatty liver disease
    Kumar, Sunil
    Srivastava, Ankita
    Palaia, Thomas
    Hall, Christopher
    Lee, Jenny
    Stevenson, Matthew
    Zhao, Chaohui Lisa
    Ragolia, Louis
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2020, 149
  • [3] GROWTH HORMONE EFFECTS ON LIPID METABOLISM IN A NON-ALCOHOLIC FATTY LIVER DISEASE IN VITRO MODEL IN HEPG2 CELLS
    Villanueva Ortega, Erendira
    Escobedo Gonzalez, Galileo
    Mendez Garcia, Lucia Angelica
    Garibay Nieto, Nayely
    Laresgoiti Servitje, Estibalitz
    Medina Bravo, Patricia
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 93 (SUPPL 2): : 20 - 20
  • [4] Cellular and molecular effects of fipronil in lipid metabolism of HepG2 and its possible connection to non-alcoholic fatty liver disease
    Pansa, Camila C.
    Molica, Leticia R.
    de Oliveira Junior, Fabiano C.
    Santello, Lara C.
    Moraes, Karen C. M.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (01)
  • [5] Oxidative Stress and Annexin A2 Differential Expression in Free Fatty Acids-Induced Non-Alcoholic Fatty Liver Disease in HepG2 Cells
    Arruda, Vinicius Marques
    Azevedo, Gabriela Tolentino
    Granato, Maria Julia Maia Goncalves
    Matos, Andre Carlos Pereira
    Araujo, Thaise Goncalves
    Guerra, Joyce Ferreira da Costa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [6] Hepatoprotecive effects of Lycium barbarum leave's ethanol extracts in non-alcoholic fatty liver disease models and HepG2 cell
    Ly, Sun Yung
    Lee, Han Sol
    ANNALS OF NUTRITION AND METABOLISM, 2023, 79 : 1070 - 1070
  • [7] Comparison of HepaRG and HepG2 cell lines to model mitochondrial respiratory adaptations in non-alcoholic fatty liver disease
    Maseko, Tumisang Edward
    Elkalaf, Moustafa
    Peterova, Eva
    Lotkova, Halka
    Stankova, Pavla
    Melek, Jan
    Dusek, Jan
    Zadnikova, Petra
    Cizkova, Dana
    Bezrouk, Ales
    Pavek, Petr
    Cervinkova, Zuzana
    Kucera, Otto
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2024, 53 (02)
  • [8] Microsomal Prostaglandin E Synthase-1 and-2: Emerging Targets in Non-Alcoholic Fatty Liver Disease
    Kotsos, Dimitrios
    Tziomalos, Konstantinos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [9] Docosahexaenoic Acid (DHA), not Leucine, May Protect HepG2 Cells from Palmitate-Induced Non-Alcoholic Fatty Liver Disease
    Baum, Jamie I.
    Carroll, Timothy G.
    Shouse, Stephanie A.
    FASEB JOURNAL, 2017, 31
  • [10] Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease
    Alkhatatbeh, Mohammad J.
    Lincz, Lisa F.
    Thorne, Rick F.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (04) : 1487 - 1492